Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)
- PMID: 26387731
- PMCID: PMC4784092
- DOI: 10.1016/j.thromres.2015.07.036
Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS)
Conflict of interest statement
The following authors have no conflict of interest to report: Harry R. Buller, Arina J. ten Cate-Hoek, Helen Philippou, Annemieke C. Bouman, Y. Whitney Cheung, Thijs E. van Mens, Jose W. Govers-Riemslag, Minka Vries, Suzanne Bleker, Jossi S. Biedermann, S. and Carina M. Stoof.
References
-
- van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124:1968–1975. - PubMed
-
- Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, et al. Apixaban for extended treatment of venous thromboembolism. N. Engl. J. Med. 2013;368:699–708. - PubMed
-
- Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N. Engl. J. Med. 2010;363:2499–2510. - PubMed
-
- Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 2001;21:1712–1719. - PubMed
-
- Undas A, Brummel-Ziedins KE, Mann KG. Anticoagulant effects of statins and their clinical implications. Thromb. Haemost. 2014;111:392–400. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources